BETAXOLOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Betaxolol Hydrochloride patents expire, and when can generic versions of Betaxolol Hydrochloride launch?
Betaxolol Hydrochloride is a drug marketed by Apotex Inc, Chartwell Rx, Eurofarma, Pharmobedient, Epic Pharma, and Kvk Tech. and is included in six NDAs.
The generic ingredient in BETAXOLOL HYDROCHLORIDE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betaxolol Hydrochloride
A generic version of BETAXOLOL HYDROCHLORIDE was approved as betaxolol hydrochloride by EPIC PHARMA on October 22nd, 1999.
